Seven Eight Capital, LP Pacific Biosciences Of California, Inc. Transaction History
Seven Eight Capital, LP
- $927 Million
- Q1 2024
A detailed history of Seven Eight Capital, LP transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 19,538 shares of PACB stock, worth $25,399. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,538
Previous 270,167
92.77%
Holding current value
$25,399
Previous $2.65 Million
97.25%
% of portfolio
0.01%
Previous 0.31%
Shares
11 transactions
Others Institutions Holding PACB
# of Institutions
293Shares Held
253MCall Options Held
1.42MPut Options Held
1.18M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.3MShares$43.3 Million0.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA26.6MShares$34.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.4MShares$30.4 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA17.6MShares$22.9 Million9.04% of portfolio
-
Nikko Asset Management Americas, Inc.12.8MShares$16.7 Million0.48% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $292M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...